Figure 5

Relationship between intracellular nilotinib in PMN cells and tumour burden in the whole population. Relationship between nilotinib concentration in mature PMN cells and (A) leucocytosis and (B) percentage of CD34⁺ cells in peripheral blood (n = 61 patients).